Two-hundred and ninety-three patients without a previous vaginal delivery were randomized to intracervical/extra-amniotic application of 0.5 mg prostaglandin E2 (PGE2) or to gel only. Of the patients who received PGE2, 18.7% were admitted before the next morning due to spontaneous abortion, bleeding or pains. No other side-effect was observed. A statistically significant dilatation of the cervical canal was found in the prostaglandin group. Thirty percent of the treated patients did not need further dilatation of the cervix 25.4% were non-responders to PGE2 and 7.7% were hyper-responders. The number of uterine perforations, pelvic inflammatory disease (PID) or retained pregnancy products were not influenced by the pretreatment with PGE2.

译文

两百九十三名先前没有阴道分娩的患者被随机分配到宫颈内/羊膜外应用0.5 mg前列腺素E2 (PGE2) 或仅凝胶。在接受PGE2的患者中,有18.7% 人因自然流产,出血或疼痛而在第二天早晨之前入院。未观察到其他副作用。在前列腺素组中发现了具有统计学意义的宫颈管扩张。30% 的接受治疗的患者不需要进一步扩张子宫颈,25.4% 是对PGE2无反应的患者,7.7% 是高反应的患者。Pge2预处理不会影响子宫穿孔,盆腔炎 (PID) 或保留的妊娠产物的数量。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录